Alkyl Amines Chemicals Ltd
Alkyl Amines Chemicals Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
2 of 4 strong
Not discussed on this call: order book.
The short version
The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9). The company expects a cautious optimism for future growth, with better times ahead after recent challenges.
From Alkyl Amines Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9).
- FY26 volume was essentially flat, with minor fluctuations (±1%) (Page 7).
- The company anticipates normal growth rates around 5-10% going forward, assuming market conditions stabilize (Pages 6-7).
- Capacity utilization across plants is currently between 60% to 85%, with sufficient capacity for the next few years without major new investments (Page 12).
- Ethylamines have sufficient capacity for the next 4-5 years; methylamines currently face some overcapacity (Page 10).
- Price increases due to raw material cost hikes may persist; margins are expected to improve but with some caution due to market uncertainties (Pages 8-9).
- The company maintains cautious optimism for better growth compared to past challenging years (Page 8).
Profitability & Margins
See what Alkyl Amines Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current capex includes completion of an ongoing new product plant at Dahej and some engineering projects, estimated around INR 80 to 90 crores for FY27 and FY28.
- No major new projects or product plants are planned immediately beyond the existing ones.
- Maintenance capex is ongoing in the range of INR 20 to 30 crores annually.
- Potential capex may arise if some R&D products currently in the pipeline progress to commercialization, but this is dependent on market stability and final investment decisions.
- The company is cautious about large investments amid market volatility and raw material uncertainties.
- Overall, no significant aggressive capex announced for near term; focus is on completing current projects and monitoring new product viability before committing further.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Alkyl Amines Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Alkyl Amines Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹387 Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Alkyl Amines Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- NOCIL Ltd (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Indo Borax & Ch. (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
- Rossari Biotech Ltd (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
Frequently Asked Questions
What were Alkyl Amines Chemicals Ltd Q4 FY26 results?
The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9). The company expects a cautious optimism for future growth, with better times ahead after recent challenges.
What is Alkyl Amines Chemicals Ltd share price analysis?
Alkyl Amines Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 44.1 with a market cap of ₹9,921 Cr. Investors should review the full earnings analysis for detailed insights.
Is Alkyl Amines Chemicals Ltd planning capital expenditure?
Current capex includes completion of an ongoing new product plant at Dahej and some engineering projects, estimated around INR 80 to 90 crores for FY27 and FY28.
Keep Alkyl Amines Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.